Publication Topic : Access to Medicines
Letter of support from NDP Leader Jack Layton re: Global Treatment Access Group
“Thank you for writing me in support of the Make Poverty History campaign’s work at the 16th International AIDS Conference in Toronto. Clearly, Prime Minister Stephen Harper’s absence speaks volumes as to where he places the HIV/AIDS crisis among his priorities. In contrast, NDP Caucus members Bill Siksay, Libby Davies, Olivia Chow, Alexa McDonough, and … Read more
Will it Deliver? WTO rules and Canada’s law on compulsory licensing – The continuing challenge of scaling up treatment access – Event at XVI International AIDS Conference
At this session, Brigitte Zirger (Health Canada), Prof. David H. Mwakyusa (Minister for Health and Social Welfare – Tanzania), Bruce Clark (Apotex), Anil Soni (Clinton Foundation), Rachel Kiddell-Monroe (Médecins Sans Frontières) and Richard Elliott (Canadian HIV/AIDS Legal Network) will present their perspectives on their experience with the Canadian law and the 2003 WTO decision, and … Read more
Letter to Prime Minister Stephen Harper re: Global Treatment Access Group
Download and send this letter to the Prime Minister and your local member of Parliament.
The Jean Chrétien Pledge to Africa Act and its Impact on Improving Access to HIV/AIDS Treatment in Developing Countries
This document assesses some of the measures taken recently to improve access to more affordable ARV therapy in developing countries. It provides a synopsis of the key WTO rules and developments, and of the Canadian law, the concrete benefits of which have yet to be realized.
Intellectual Property and Access to HIV/AIDS Treatment – Case Studies
Until now, India, Brazil and Thailand have been among the biggest generic ARV producers, both for their own people and for export. This production has been crucial for the supply of affordable treatment in the developing world. It has resulted in competition between producers, which has reduced the price of many ARVs from as much … Read more